Healthcare · Diagnostics Research · NASDAQ
| Market cap | $3.49B |
|---|---|
| Trailing P/E | 20.6 |
| FCF yield | 3.6% |
| Revenue growth (YoY) | +16.0% |
| EPS growth (YoY) | +73.8% |
| FCF/share growth (YoY) | +92.5% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Veracyte, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Apr 7, 2026 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Dec 15, 2025 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Jul 10, 2025 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Nov 11, 2023 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Oct 15, 2023 |